CBNK+Ab (GC Cell/Artiva Biotherapeutics)

N/A

Report date: 2025/06/11 10:34:51

Base Information

Drug NameCBNK+Ab (GC Cell/Artiva Biotherapeutics)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapyBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionNatural killer cells stimulantsImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGC Cell Corp

China Registration ClassN/A

Develop Information

Active CompaniesGC Cell Corp Artiva Biotherapeutics Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A